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Background. Excessive cytokine production has been implicated in the development of organ failure. Polymorphic sites in
cytokine genes have been shown to affect levels of production in vitro and may influence cytokine production in vivo. The
aims of this study were to determine if cytokines or their genetic polymorphisms were related to outcome after abdominal
aortic aneurysm (AAA) repair.
Methods. A prospective study of 135 patients undergoing open AAA repair. Plasma levels of TNF-alpha, IL-1beta, IL-6 and
IL-10 were measured 24 h post-operatively and genotypes for the TNF-alpha 2308, IL-1beta þ 3953, IL-6 2174, IL-10
21082 and IL-10 2592 polymorphisms were determined for each patient.
Results. After elective AAA high levels of IL-10 were associated with both prolonged critical care (P , 0.001) and hospital
stay (P ¼ 0.001). The presence of a G allele at the IL-6 2174 locus was associated with a higher incidence of organ failure
(P ¼ 0.04) and an A allele at TNF-alpha 2308 with prolonged critical care stay (P ¼ 0.03). After ruptured AAA the
development of multi-organ failure was associated with high levels of IL-6 (P ¼ 0.01) and TNF-alpha (P ¼ 0.04). High
TNF-alpha levels were also associated with mortality (P ¼ 0.01).
Conclusion. Post-operative cytokine levels are related to outcome after AAA repair. Cytokine gene polymorphisms may
provide a method for determining which patients are at high risk of complications.
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Introduction
Multiple organ failure was first described in patients
who had undergone emergency repair of ruptured
abdominal aortic aneurysms (AAA) in 1973.1 Today,
organ failure remains a significant cause of morbidity
and mortality after AAA repair, particularly after
rupture.2 This is due to an overwhelming post-
operative systemic inflammatory response caused by
the failure to maintain control of the pro-inflammatory
stimulus of surgery. Some of the prime mediators of
the inflammatory responses to surgery are cytokines.
Excessive production of pro-inflammatory cytokines
such as interleukin (IL)-6 and IL-1b cause dysfunction
of the cardiovascular, renal, gastro-intestinal, respirat-
ory and central nervous systems that in combination
manifests as multiple organ dysfunction and may lead
to multiple organ failure.3
The inflammatory response to AAA repair is caused
by the injury of surgery and, in the case of ruptured
AAA, the additional insult of haemorrhage. The
degree of inflammation caused by any particular
stimulus may be affected by factors peculiar to each
individual patient and one such factor is the genetic
constitution of the patient. Cytokine genes contain
polymorphic sites and in some cases these poly-
morphic sites have been shown to affect absolute
levels of cytokine production in in vitro experiments.4
To date the effect of cytokine gene polymorphisms on
the outcome of AAA repair has not been studied.
Since cytokines are implicated in the pathogenesis
of organ failure after AAA repair the levels of
circulating cytokines may be related to outcome in
these patients and in addition, cytokine gene poly-
morphisms may also influence outcome. In previous
work we have found that in patients undergoing
elective AAA repair, the cytokine gene polymorph-
isms in the IL-1b, IL-6, IL-10 and TNF-a genes
had little effect on baseline cytokine levels or the
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magnitude of cytokine response to surgery.5 However,
the failure to demonstrate an association does not
necessarily mean that no such association exists. Also,
it is entirely possible that post-operative cytokine
levels may be independent of polymorphisms in their
genes and each or both may be related to clinical
outcome, either as causal factors or secondary mar-
kers. The aims of this study were to determine in
patients undergoing AAA repair, firstly, whether
plasma cytokine levels are related to outcome, and
secondly, whether the bi-allelic genetic polymorph-
isms in the TNF-a, IL-1b, IL-6 and IL-10 genes detailed
above are related to outcome.
Methods
Patients
A prospective study of 135 patients undergoing open
AAA repair was performed. Patients were divided
into those that had elective AAA repair (EAAA) ðn ¼
100Þ and those with ruptured AAA (RAAA) ðn ¼ 35Þ:
Aneurysm rupture was defined as the presence of free
intra-peritoneal blood and/or retroperitoneal haema-
toma at laparotomy. All patients with ruptured AAA
irrespective of the degree of pre-operative cardiovas-
cular collapse were included in the same outcome
group. Those patients who died intra-operatively were
not included in the study, as were patients who had
undergone emergency laparotomy for symptomatic
but non-ruptured AAA. Procedures performed via
both the transperitoneal and retroperitoneal
approaches were included as were those patients
with supra-renal aneurysms. The study was approved
by the local ethics committee.
For each patient, from the first post-operative day
until hospital discharge or death, the presence of organ
failure in the previous 24 h was recorded on a daily
basis. Failure in the following organ systems (accord-
ing to the definitions of Knaus et al.6) was recorded:
cardiovascular, respiratory, renal, haematological and
neurological. ‘Any organ failure’ was defined as one or
more organ systems failing during a single 24 h period
and ‘multi-organ failure’ was defined as the presence
of two or more organ system failures during the same
24 h period. In addition the time (in days) to discharge
from both the critical care unit and hospital was
recorded for each patient. All patients in the study
were cared for on critical care units that consisted of
combined intensive care and high dependency beds.
Mortality was defined as death prior to hospital
discharge.
Measurement of plasma cytokine levels and genotyping
Blood samples were taken at the induction of
anaesthesia for the determination of each patients
genotype and 24 h post-operatively for the measure-
ment of plasma cytokine levels. Genotypes were
determined by induced heteroduplex genotyping
and plasma cytokine levels were determined by
enzyme-linked immuno-sorbent assay (ELISA). The
methods used (including assay ranges and variability)
have previously been described.5
Outcome measures
For the purposes of determining the relationships
between clinical outcome and 24 h post-operative
plasma cytokine levels, in the EAAA group patients
were dichotomised into equal groups based on the
length of critical care and total hospital stay. In
addition, the EAAA group was divided into those
who developed any organ failure at any point during
the post-operative period and those who did not. In
the RAAA group, the outcome measures were in-
hospital mortality and the development of multi-
organ failure at any point during the post-operative
period.
To determine the relationships between clinical out-
come and genetic polymorphisms, the presence of each
allele at each locus was compared to clinical outcome in
each patient group. Also, individual genotypes at each
locuswere comparedwith clinical outcome. The clinical
outcomesmeasured ineachpatientgroupwere the same
as those above except that in the case of the EAAAgroup
the length of critical care and hospital stay was
compared between alleles directly rather than being
dichotomised.
Statistical analysis
Comparisons between 24 h cytokine levels and the
different outcome groups were made using a Mann–
Whitney U test. Comparisons between those patients
with and without each allele at each locus were made
using Fishers exact test where the outcome data was
dichotomous (for example mortality) and Mann–
Whitney U tests where the outcome data was
continuous (for example length of critical care stay).
This study was designed as a pilot study, and since
previous data regarding both the influence of cytokine
gene polymorphisms and post-operative cytokine
levels on clinical outcome was either conflicting or
non-existent the determination of a standardized
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difference to enable a formal power calculation to be
made was not possible.
Results
Demographics
The 100 patients with EAAA had a median age of 71
years (range 48–85 years) and 79 (0.79) were male. In
the RAAA group the median age was 72.5 years (range
59–80 years) and 31 (0.89) were male. All genetic loci
were in Hardy–Weinberg equilibrium (the predicted
genotype frequencies derived from the Hardy–Wein-
berg equation using the observed allele frequencies,
were not significantly different from the observed
genotype frequencies).
Elective AAA: cytokine levels
Of the 100 patients with EAAA in the study 43 (0.43)
developed any organ failure, 54 (0.54) had a critical
care stay of greater the 2 days and 55 (0.55) had a
hospital stay of greater than 9 days. Therefore, for the
purposes of assessing outcome the patients were
divided into those who developed organ failure,
those who stayed on the critical care wards for more
than two days and those with post-operative hospital
stays of greater than 9 days.
IL-1b was only detectable in a small proportion of
the patients in the EAAA group at 24 h and so the
proportion of patients with detectable levels of IL-1b
were compared. Data was available for 90 patients in
the EAAA group (data for 10 patients was unavailable
due to a manufacturing defect in the ELISA kits used
in the study which could not be rectified) and so the
numbers with each outcome measure outlined above
are reduced. In those 40 patients who developed any
organ failure nine patients (0.225) had detectable levels
of IL-1b compared to 11 patients (0.220) in the group
who did not develop any organ failure (50 patients)
(P ¼ 1:00; Fishers exact test). 0.244 of those patients
with long critical care stays ðn ¼ 49Þ had detectable
levels of IL-1b at 24 h compared to 0.220 of those who
had shorter critical care stays ðn ¼ 41Þ (P ¼ 0:62;
Fishers exact test). There was no significant difference
in the proportion of patients with detectable levels of
IL-1b between those with long ðn ¼ 50Þ and those with
short ðn ¼ 40Þ hospital stays (0.196 vs 0.195, P ¼ 1:00;
Fishers exact test).
Median TNF-a, IL-6 and IL-10 levels for each of the
outcome groups are shown in Table 1. There was no
significant difference in either TNF-a or IL-6 levelsTa
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between those with poor or good outcomes. Patients
with longer critical care and hospital stays had higher
post-operative IL-10 levels.
Elective AAA: cytokine gene polymorphisms
For the purposes of determining outcome the incidence
of organ failure and the median lengths of critical care
and post-operative stay were compared directly
between patients grouped according to the presence or
absence of each particular allele at each locus.
The incidence of organ failure was only influenced
by the presence of an IL-62174 G allele, those patients
who possessed the G allele at this locus had a higher
incidence of organ failure than those who did not
(0.481 vs 0.211, P ¼ 0:04; Fishers exact test) (Table 2).
Those patients who possessed an A allele at the TNF-a
2308 locus had significantly longer critical care stays
than those who did not possess this allele (median
(range) length of stay 3 days (1–31) vs 2 days (1–20),
P ¼ 0:03; Mann–Whitney U test) (Table 3). None of the
alleles at any locus had any significant effect on the
length of total post-operative hospital stay (Table 4).
Ruptured AAA: cytokine levels
In the RAAA group, the two outcome measures were
mortality (death vs survival to hospital discharge) and
the development of multi-organ failure. Of the 35
patients with ruptured AAA who survived the initial
operation, 16 patients died (0.444) and 21 (0.060)
developed multi-organ failure.
Twenty-eight patients in the RAAA group had data
available for IL-1b. There was no significant difference
in the proportions of patients with detectable IL-1b
levels at 24 h after RAAA repair between those who
developed multi-organ failure ðn ¼ 17Þ and those who
did not ðn ¼ 11Þ; (0.353 vs 0.273, P ¼ 1:00; Fishers exact
test). 0.556 of patients who died ðn ¼ 12Þ had detect-
able levels of IL-1b at 24 h compared to 0.0368 of those
who survived ðn ¼ 16Þ (P ¼ 0:43; Fishers exact test).
Median TNF-a, IL-6 and IL-10 levels for each of the
outcomes are shown in Table 5. There was no
association between IL-10 and either multi-organ
failure or survival. Patients who developed multi-
organ failure had significantly higher levels of both IL-
6 and TNF-a than those who did not, and TNF-a levels
were significantly higher in those patients who died.
Ruptured AAA: cytokine gene polymorphisms
None of the loci studied had any significant effect on
mortality or the development of multi-organ failure
after RAAA repair. The differences in the incidence of
multi-organ failure and mortality between patients
Table 2. EAAA: the incidence of any organ failure in those with each allele present or absent at each locus
Locus Allele Allele present Allele absent P*
n n (organ failure) (%) n n (organ failure) (%)
TNF-a 2308 G 88 36 (40.9) 12 7 (58.3) 0.35
A 38 20 (52.6) 62 23 (37.1) 0.15
IL-1b þ 3953 C 98 41 (41.8) 2 2 (100) 0.18
T 44 19 (43.2) 56 24 (42.9) 1.00
IL-6 2174 G 81 39 (48.1) 19 4 (21.1) 0.04
C 71 30 (42.3) 29 13 (44.8) 0.83
IL-10 21082 G 68 26 (38.2) 32 17 (53.1) 0.20
A 78 35 (44.9) 22 8 (36.4) 0.63
*Fishers exact test.
Table 3. EAAA: the length of critical care stay in those with each allele present or absent at each locus
Locus Allele Allele present Allele absent P*
n Median length of critical care stay (days) Range n Median length of critical care stay (days) Range
TNF-a 2308 G 88 2 (1–31) 12 3 (1–12) 0.25
A 38 3 (1–31) 62 2 (1–20) 0.03
IL-1b þ 3953 C 98 3 (1–31) 2 7 (2–12) 0.52
T 44 2 (1–20) 56 3 (1–31) 0.23
IL-6 2174 G 81 3 (1–31) 19 2 (1–5) 0.37
C 71 2.5 (1–15) 29 3 (1–31) 0.29
IL-10 21082 G 68 2 (1–31) 32 3 (1–20) 0.21
A 78 3 (1–31) 22 2 (1–5) 0.09
*Mann–Whitney U test.
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with andwithout each allele at each locus are shown in
Tables 6 and 7, respectively.
Discussion
This study demonstrates that plasma cytokine levels
are related to outcome after AAA repair and that
cytokine gene polymorphisms show a significant but
lesser relationship to outcome. Specifically, after
elective AAA repair high levels of the predominantly
anti-inflammatory cytokine IL-10 at 24 h post-opera-
tively are associated with prolonged critical care and
hospital stay. After surgery for ruptured AAA high
plasma levels of the pro-inflammatory cytokines TNF-
a and IL-6 were associated with poor outcome. High
24 h levels of TNF-a were associated with the
development of multi-organ failure during the post-
operative period and in-hospital mortality. High IL-6
levels were associated with subsequent multi-organ
failure. The significant associations between the
cytokine gene polymorphisms studied and outcome
were the association of a G allele at the IL-62176 locus
with the development of post-operative organ failure
and the association of an A allele at the TNF-a 2308
locus with prolonged post-operative critical care
requirements after elective AAA repair.
The cytokine response to AAA repair has been
examined in multiple small studies, recently reviewed
by Swartbol et al.7 The majority of these studies have
identified that there is a measurable pro-inflammatory
response to AAA repair but few have attempted to
correlate this response to outcome and where this has
been examined no significant associations have been
identified. The association of high IL-10 but not TNF-
a, IL-1b and IL-6 levels with outcome after elective
AAA repair demonstrated in this study is unexpected
but not unfeasible. Complications following elective
AAA repair are frequently not a result of inflammation
driven pathological processes but rather isolated
respiratory or cardiac complications.8 It has been
proposed that excessive circulating IL-10 may be
associated with poor clinical outcome by its immuno-
suppressive effects9,10 and it may be that in the elective
group of patients where the inflammatory stimulus is
relatively low compared to the ruptured group it is the
degree of anti-inflammatory response generated that
influences outcome more than the pro-inflammatory
response.
In contrast to the elective group, in the ruptured
group it was high levels of the pro-inflammatory
cytokines TNF-a and IL-6 that were associated with
poor outcome. In this group of patients complications
are more commonly due to ‘sepsis driven’ pathology
such as multi-organ failure.11 In addition to the
operative procedure the ruptured group have an
additional pro-inflammatory stimulus of pre-operat-
ive haemorrhagic shock. The initial insult causes
priming of inflammatory pathways. The second insult
causes an exaggerated response to that that would
occur if it had occurred in isolation. This ‘double-hit’ is
thought to contribute to the excessive systemic
inflammation seen in such patients and mediates
progression to multiple organ failure.12 It is possible
Table 4. EAAA: the length of hospital stay in those with each allele present or absent at each locus
Locus Allele Allele present Allele absent P*
n Median length of hospital stay (days) Range n Median length of hospital stay (days) Range
TNF-a 2308 G 85 10 (5–76) 10 10 (7–36) 0.77
A 36 9 (5–76) 59 10 (6–50) 0.59
IL-1b þ 3953 C 93 10 (5–76) 2 24 (12–36) 0.13
T 42 10 (5–38) 53 10 (6–76) 0.97
IL-6 2174 G 76 10 (5–76) 19 9 (7–38) 0.24
C 67 10 (6–50) 28 9 (5–76) 0.52
IL-10 21082 G 66 10 (6–76) 29 9 (5–38) 0.42
A 73 10 (5–76) 22 9 (6–38) 0.64
*Mann–Whitney U test. Patients who died ðn ¼ 5Þ not included.
Table 5. RAAA: comparison of median (range) cytokine levels (pg/ml) in each of the outcome groups
Multi-organ failure Survival
No ðn ¼ 14Þ Yes ðn ¼ 21Þ P Survived ðn ¼ 19Þ Died ðn ¼ 16Þ P
TNF-a 6.2 (0.0–114.4) 28.7 (0.0–451.5) 0.04 0.0 (0.0–332.8) 54.5 (8.8–451.5) 0.01
IL-6 182.9 (0.0–1226.8) 741.6 (32.53–4205.3) 0.02 186.4 (0.0–1697.4) 741.6 (12.1–4205.3) 0.09
IL-10 5.8 (0.0–63.45) 12.2 (1.9–202.1) 0.21 7.0 (0.0–63.45) 12.2 (1.9–202.1) 0.41
All P values calculated using Mann–Whitney U test.
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that in the ruptured group the association of high
levels of pro-inflammatory cytokines and poor out-
come reflects true systemic inflammation whereas in
the elective group the degree of systemic inflammation
is relatively limited by anti-inflammatory mechanisms.
This anti-inflammatory responsemay be responsible for
some of the morbidity seen after elective AAA repair.
The associations between the cytokine gene poly-
morphisms and outcome have to be viewed with
caution. There was no general trend for one particular
allele to be associated with a poor outcome in both
patient groups or with the different outcome measures
in each patient group. Indeed, from this study it would
appear that the measurement of serum cytokine levels
immediately after surgery is a better predictor of
outcome than an individual patient’s genotype.
This is the only study to have examined cytokine
gene polymorphisms in relation to outcome after AAA
repair and so the results cannot be easily compared. In
studies of other acute inflammatory driven processes
again, few positive associations have been identified.
In acute pancreatitis TNF-a and IL-1b genes have
shown no association with the development or
severity of disease.13,14 In patients with sepsis evi-
dence for the role of cytokine gene polymorphisms is
mixed. The TNF-a 2308 polymorphism has been
shown to be associated with both a many fold increase
in mortality and no effect on mortality.15,16
The limitations of this study are principally the
relatively low numbers of patients studied, particu-
larly in the ruptured AAA group. In addition, the
ELISA method used to determine cytokine levels is
subject to considerable variability17 but our results are
comparable to other laboratories.5 The reasons to
study cytokine gene polymorphisms in relation to
clinical outcome are principally academic. The associ-
ation of a particular gene with outcome may suggest
an aetiological role for that gene or its product in the
pathogenesis of the condition being studied.
Results were not standardized according to operat-
ive procedure. In previous work, we have determined
that intra-operative factors have minimal effects on the
cytokine response to surgery.5 All types of open repair
were included in this study, as were patients with
supra-renal aneurysms. This is justified since our
hypothesis was to determine whether post-operative
cytokine levels and/or cytokine genotypes were
related to outcome. To restrict the study to only
patients with a ‘standard’ open AAA repair would
have limited the ability to detect a difference between
the various outcome groups.
The time point chosen to draw blood samples for
measurement of plasma cytokine levels may have
influenced the results of the study. The 24 h post-
operative time period was chosen since the authors felt
that this was the most clinically relevant time period
Table 6. RAAA: the incidence of multi-organ failure in those with each allele present or absent at each locus
Locus Allele Allele present Allele absent P*
n n (multi-organ failure) (%) n n (multi-organ failure) (%)
TNF-a 2308 G 31 17 (54.8) 4 4 (100.0) 0.13
A 14 9 (64.3) 21 12 (57.1) 0.74
IL-1b þ 3953 C 34 21 (61.8) 1 0 (0.0) 0.40
T 15 8 (53.3) 20 13 (65.0) 0.51
IL-6 2174 G 31 18 (58.1) 4 3 (75.0) 0.64
C 24 13 (54.2) 11 8 (72.7) 0.46
IL-10 21082 G 21 12 (57.1) 14 9 (64.3) 0.74
A 30 18 (60.0) 5 3 (60.0) 1.00
*Fishers exact test.
Table 7. RAAA: mortality in those with each allele present or absent at each locus
Locus Allele Allele present Allele absent P*
n n (mortality) (%) n n (mortality) (%)
TNF-a 2308 G 31 12 (38.7) 4 3 (75.0) 0.29
A 14 7 (50.0) 21 8 (38.1) 0.51
IL-1b þ 3953 C 34 15 (44.1) 1 0 (0.0) 1.00
T 15 6 (40.0) 21 9 (42.9) 1.00
IL-6 2174 G 31 13 (41.9) 4 2 (50.0) 1.00
C 24 10 (41.7) 11 5 (45.5) 1.00
IL-10 21082 G 21 11 (52.4) 14 4 (28.6) 0.30
A 30 11 (36.7) 5 4 (80.0) 0.14
*Fishers exact test.
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that would reflect ‘day 1’ blood samples. Whilst some
of the cytokines to be examined may have passed their
peak levels, the same time point was used for all
patients and should have been comparable between
patients. However, for IL-1b very few patients had
detectable levels of this cytokine, which has been
shown to peak very soon after aortic surgery18 and this
may have contributed to the lack of associations seen.
In conclusion, we have shown that post-operative
cytokine levels reflect the inflammatory response to
surgery and are related to clinical outcome. They may
be useful prognostic indicators, especially in ruptured
AAA. Whilst the precise role of cytokine gene
polymorphisms in relation to outcome after AAA
repair is unclear further investigation is required to
ascertain whether they may also be useful prognostic
indicators in multi-organ failure.
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